ARNTL2 is an indicator of poor prognosis, promotes epithelial-to-mesenchymal transition and inhibits ferroptosis in lung adenocarcinoma

OBJECTIVES: ARNTL2, as a circadian transcription factor, has been recently proposed to play an important role in a variety of tumors. however, the role of ARNTL2 in lung carcinogenesis and progression remains unclear. The purpose of this study was to investigate the effect of ARNTL2 on the clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Huan, Shan, Guangyao, Jin, Xing, Yu, Xiangyang, Bi, GuoShu, Feng, Mingxiang, Wang, Hao, Lin, Miao, Zhan, Cheng, Wang, Qun, Li, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563212/
https://www.ncbi.nlm.nih.gov/pubmed/36228410
http://dx.doi.org/10.1016/j.tranon.2022.101562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563212/
https://www.ncbi.nlm.nih.gov/pubmed/36228410
http://dx.doi.org/10.1016/j.tranon.2022.101562

Ejemplares similares